间质性肺疾病与肿瘤标记物及血清因子的关系研究进展
Research Progress on the Relationship between Interstitial Lung Disease and Tumor Markers and Serum Factors
DOI: 10.12677/ACM.2020.106140, PDF,   
作者: 段兴秋：大理大学临床医学院，云南 大理
关键词: 间质性肺疾病；肿瘤标记物；血清因子；Interstitial Lung Disease； Tumor Marker； Serum Factor
摘要: 近年来，间质性肺疾病引起了人们越来越多的重视，学者对其的研究也越来越多。众多学者尤其是国外学者研究发现：① 间质性肺疾病患者血清中部分肿瘤标记物，如CEA、CA19-9、SCC等会有一定程度的升高，但需警惕存在继发或者合并肿瘤的情况；② 不同原因所致的间质性肺疾病，血清肿瘤标记物升高的水平不同；③ 肿瘤标记物升高的水平可能与疾病的严重程度、治疗效果及转归有关；④ 除肿瘤标记物外，间质性肺疾病患者血清因子也有一定程度的升高，部分血清因子具有预测结局的作用。
Abstract: In recent years, interstitial lung disease has attracted more and more attention, and more and more scholars have studied it. Many scholars, especially foreign scholars, have found that: ① Some tumor markers in the serum of patients with interstitial lung disease, such as CEA, CA19-9, SCC, etc., will increase to a certain extent, but it is necessary to be alert for the presence of secondary or combined tumors Situation; ② Interstitial lung disease caused by different reasons, the level of elevated serum tumor markers is different; ③ The increased level of tumor markers may be related to the severity of the disease, treatment effect and outcome; ④ In addition to tumor markers, the serum factor of patients with interstitial lung disease also increased to a certain extent, and some serum factors have the effect of predicting the outcome.
文章引用：段兴秋. 间质性肺疾病与肿瘤标记物及血清因子的关系研究进展[J]. 临床医学进展, 2020, 10(6): 914-919. https://doi.org/10.12677/ACM.2020.106140

参考文献

[1] 万学红, 卢雪峰, 主编. 诊断学[M]. 第8版. 北京: 北京人民卫生出版社, 2013.
[2] Myall Katherine J,West Alex,Kent Brian D. (2019) Sleep and Interstitial Lung Disease. Current Opinion in Pulmonary Medicine, 25, 623-628. [Google Scholar] [CrossRef] 
[3] Clarson, L.E., Bajpai, R., Whittle, R., et al. (2020) Interstitial Lung Disease Is a Risk Factor for Ischaemic Heart Disease and Myocardial Infarction. Heart, 2020, 1-7. [Google Scholar] [CrossRef] [PubMed]
[4] 杜瑞娇. 肿瘤标记物与肺间质纤维化的相关性分析及临床观察[D]: [硕士学位论文]. 大连: 大连医科大学, 2016.
[5] 张书印, 丁选胜, 方芸. 细胞角蛋白19片断在间质性肺病诊断中的临床意义[J]. 药学与临床研究, 2017, 25(4): 318-320.
[6] 林蕊艳, 张新, 李晓辉, 胥振扬. 间质性肺疾病血清肿瘤标记物升高的临床意义[J]. 中国临床药理学杂志, 2011, 27(8): 623-625.
[7] Sanguinetti, C.M., Riccioni, G., Marchesani, F., et al. (1995) Bronchoalveolar Lavage Fluid Level of Carcinoembryonic Antigen in the Diagnosis of Peripheral Lung Cancer. Monaldi Archives for Chest Disease, 50, 177-182.
[8] Tao, H., Onoda, H., Okabe, K., et al. (2018) The Impact of Coexisting Lung Diseases on Outcomes in Patients with Pathological Stage I Non-Small-Cell Lung Cancer. Interactive Cardiovascular and Thoracic Surgery, 26, 1009-1015. [Google Scholar] [CrossRef] [PubMed]
[9] Sekihara, K., Aokage, K., Oki, T., et al. (2018) Long-Term Survival after Complete Resection of Non-Small-Cell Lung Cancer in Patients with Interstitial Lung Disease. Interactive Cardiovascular and Thoracic Surgery, 26, 638-643. [Google Scholar] [CrossRef] [PubMed]
[10] 王玉超, 杨晓红, 邬超. 特发性肺纤维化合并肺癌患者血液肿瘤标志物CEA、CA199、CA125、CA153检测分析[J]. 山东医药, 2013, 53(29): 78-79.
[11] 李文飞. 肿瘤标志物与不同类型间质性肺病关系探讨[D]: [硕士学位论文]. 天津: 天津医科大学, 2019.
[12] 熊晓静. CTD-ILD患者血清学指标的临床意义[D]: [硕士学位论文]. 乌鲁木齐: 新疆医科大学, 2019.
[13] 朱红林, 杜倩, 谌威霖, 左晓霞, 李全贞, 刘思佳. 系统性硬化症血清细胞因子表达谱变化及调控机制[J]. 北京大学学报(医学版), 2019, 51(4): 716-722.
[14] Ishikawa, Y., Iwata, S., Hanami, K., et al. (2018) Relevance of Interferon-Gamma in Pathogenesis of Life-Threatening Rapidly Progressive Interstitial Lung Disease in Patients with Dermatomyositis. Arthritis Research & Therapy, 20, 240. [Google Scholar] [CrossRef] [PubMed]
[15] Calabrese, F., Lunardi, F. and Giacometti, C. (2008) Over Expression of Squamous Cell Carcinoma Antigen in Idiopathic Pulmonary Fibrosis: Clinico Pathological Correlations. Thorax, 63, 795-802. [Google Scholar] [CrossRef] [PubMed]
[16] Xu, L., Bian, W., Gu, X.H., et al. (2017) Differing Expression of Cytokines and Tumor Markers in Combined Pulmonary Fibrosis and Emphysema Compared to Emphysema and Pulmonary Fibrosis. COPD, 14, 245-250. [Google Scholar] [CrossRef] [PubMed]
[17] 张立, 王强. 多发性肌炎(PM)/皮肌炎(DM)相关的肺间质病变发(ILD)病机制的研究进展[J]. 复旦学报(医学版), 2015, 42(2): 267-272.
[18] 曹路, 高宝安, 官莉, 陈世雄. 乙酰半胱氨酸+甲基强的松龙对IIP患者血气指标、肺功能及血清炎症因子的影响[J]. 中华肺部疾病杂志(电子版), 2019, 12(6): 738-742.
[19] Mukae, H., Sakito, O., Oda, H., Senju, R., et al. (1991) Two Cases of Interstitial Pneumonitis with Marked Increase of Tumor-Associated Carbohydrate Antigens in Serum. Nihon Kyōbu Shikkan Gakkai Zasshi, 29, 611-617.
[20] Seike, M., Usuki, J., Uematsu, K., et al. (1995) Giant Cell Interstitial Pneumonia in a Metal Grinder with an Abnormally High Level of Serum CA19-9. Nihon Kyōbu Shikkan Gakkai Zasshi, 33, 894-899.
[21] Sugiyama, M., Ito, K., Iyonaga, K., et al. (1997) Idiopathic Interstitial Pneumonia Associated with a High Level of CA19-9 in Serum and with CA19-9 in Lung Tissue. Nihon Kyōbu Shikkan Gakkai Zasshi, 35, 561-565.
[22] 牟晓燕, 林殿杰, 辛洪涛. 肺间质纤维化的分子生物学发病机制及治疗新进展[J]. 国际呼吸杂志, 2006(12): 928-931.
[23] Truchetet, M.E., Brembilla, N.C., Montanari, E., et al. (2011) Increased Frequency of Circulating Th22 in Addition to Th17 and Th2 Lymphocytes in Systemic Sclerosis: Association with Interstitial Lung Disease. Arthritis Research & Therapy, 13, R166. [Google Scholar] [CrossRef] [PubMed]
[24] 赵素霞, 王燕. 细胞因子与间质性肺疾病的发病机制[J]. 国际呼吸杂志, 2006(8): 625-628.
[25] Jiang, S., Wang, Z., Ouyang, H., et al. (2016) Aberrant Expression of Cytokine Interleukin 9 along with Interleukin 4 and Interferon γ in Connective Tissue Disease-Associated Interstitial Lung Disease: Association with Severity of Pulmonary Fibrosis. Archives of Medical Science, 12, 101-106. [Google Scholar] [CrossRef] [PubMed]
[26] Kawasumi, H., Gono, T., Kawaguchi, Y., et al. (2014) IL-6, IL-8, and IL-10 Are Associated with Hyperferritinemia in Rapidly Progressive Interstitial Lung Disease with Polymyositis/Dermatomyositis. BioMed Research International, 2014, Article ID: 815245. [Google Scholar] [CrossRef] [PubMed]
[27] Liu, Y., Zhang, B., Lei, Y., et al. (2020) Serum Levels of Interleukin-34 and Clinical Correlation in Patients with Primary Sjögren’s Syndrome. International Journal of Rheumatic Diseases, 23, 374-380. [Google Scholar] [CrossRef] 
[28] Shen, H., Xia, L. and Lu, J. (2013) Interleukin-4 in Rheumatoid Arthritis Patients with Interstitial Lung Disease: A Pilot Study. The Indian Journal of Medical Research, 138, 919-921.
[29] 孙迪, 程哲, 蒋天赐, 李鹏飞, 贾留群, 王婷婷, 郑曹沛, 李妍, 堕梦洁. 肺功能和KL-6在抗合成酶综合征相关间质性肺疾病与特发性肺纤维化中的特点及临床意义[J]. 中华医学杂志, 2020(10): 748-752.
[30] Kim, H.C., Choi, K.H., Jacob, J., et al. (2020) Prognostic Role of Blood KL-6 in Rheumatoid Arthritis-Associated Interstitial Lung Disease. PLoS One, 15, e0229997. [Google Scholar] [CrossRef] [PubMed]
[31] 曹雪涛. 医学免疫学-8版[M]. 北京: 北京人民卫生出版社, 2013.
[32] Sfriso, P., Cozzi, F., Oliviero, F., et al. (2012) CXCL11 in Bronchoalveolar Lavage Fluid and Pulmonary Function Decline in Systemic Sclerosis. Clinical and Experimental Rheumatology, 30, S71-S75.
[33] Guo, L., Yang, Y., Liu, F., et al. (2019) Clinical Research on Prognostic Evaluation of Subjects with IPF by Peripheral Blood Biomarkers, Quantitative Imaging Characteristics and Pulmonary Function Parameters. Archivos de Bronconeumología, in Press. [Google Scholar] [CrossRef] [PubMed]
[34] 贺新伟, 骆琼珍, 尚颖, 高占成. CCL18在结缔组织病相关间质性肺疾病BALF中的表达及临床意义[J]. 中华医学杂志, 2019, 99(38): 2976-2981.
[35] Elhai, M., Avouac, J. and Allanore, Y. (2020) Circulating Lung Biomarkers in Idiopathic Lung Fibrosis and Interstitial Lung Diseases Associated with Connective Tissue Diseases: Where Do We Stand? Seminars in Arthritis and Rheumatism, in Press. [Google Scholar] [CrossRef] [PubMed]
[36] Wu, M., Baron, M., Pedroza, C., et al. (2017) CCL2 in the Circulation Predicts Long-Term Progression of Interstitial Lung Disease in Patients with Early Systemic Sclerosis: Data from Two Independent Cohorts. Arthritis & Rheumatology, 69, 1871-1878. [Google Scholar] [CrossRef] [PubMed]
[37] Cao, M., Sheng, J., Qiu, X., et al. (2019) Acute Exacerbations of Fibrosing Interstitial Lung Disease Associated with Connective Tissue Diseases: A Population-Based Study. BMC Pulmonary Medicine, 19, Article No.: 215. [Google Scholar] [CrossRef] [PubMed]
[38] Kawamura, K., Ichikado, K., Anan, K., et al. (2020) Monocyte Count and the Risk for Acute Exacerbation of Fibrosing Interstitial Lung Disease: A Retrospective Cohort Study. Chronic Respiratory Disease, 17, 1-8. [Google Scholar] [CrossRef] [PubMed]
[39] Efared, B., Ebang-Atsame, G., Rabiou, S., et al. (2017) The Diagnostic Value of the Bronchoalveolar Lavage in Interstitial Lung Diseases. Journal of Negative Results in BioMedicine, 16, Article No.: 4. [Google Scholar] [CrossRef] [PubMed]
[40] Hara, Y., Shinkai, M., Kanoh, S., et al. (2017) Arterial Carboxyhemoglobin Measurement Is Useful for Evaluating Pulmonary Inflammation in Subjects with Interstitial Lung Disease. Internal Medicine, 56, 621-626. [Google Scholar] [CrossRef] [PubMed]
[41] Zhang, T., Yuan, F., Xu, L., et al. (2020) Characteristics of Patients with Primary Sjögren’s Syndrome Associated Interstitial Lung Disease and Relevant Features of Disease Progression. Clinical Rheumatology, 39, 1561-1568. [Google Scholar] [CrossRef] [PubMed]

为你推荐